Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
33 results
D3.265 - Biphasic anaphylaxis secondary to polyethylene glycol in a pediatric patient: a case report
D3.268 - Chronic Allergen Exposure Induces Accumulation of IgE Plasma Cells in the Lung, Leading to Local IgE Antibody Production
D3.269 - Drug-Induced Anaphylaxis in Children: A Comparative Analysis of Inpatient vs. Outpatient Settings
D3.270 - A novel workflow for cell metabolomics: impact of anaphylaxis in a human endothelial system
D3.272 - Safety and Efficacy of Vancomycin and Other Antimicrobial Drug Desensitization in Pediatric Patients
D3.273 - Assessing Anaphylaxis in COVID-19 vaccines: Application of amended Brighton Collaboration Criteria
D3.274 - Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria
D3.275 - Anaphylaxis caused by polyhexanide
D3.276 - Acalabrutinib as premedication in platinum agents desensitization protocols: a case series supporting its role in enhancing tolerance with a repeatible efficacity
D3.277 - Features of severe anaphylaxis in children, data from the Moscow Pediatric Register
D3.373 - Hives and hidden codes: detection of miRNA in chronic spontaneous urticaria patients - pilot study
D3.369 - Childhood exhaled nitric oxide levels predict new-onset allergic rhinitis in adolescence and young adulthood
D3.370 - Inverse Association between Mitochondrial DNA Copy Number and Atopic Dermatitis in Schoolchildren
D3.371 - Impact of sensitization to main allergen molecules during childhood on adult asthma, atopic dermatitis, rhinitis and food allergy in the BAMSE cohort
D3.372 - SLC27A2 marks lipid peroxidation in nasal epithelial cells driven by type 2 inflammation in chronic rhinosinusitis with nasal polyps
D3.374 - Assessment of leukotriene E4 as a long term marker of inflammation between regular maintenance (36 weeks therapy) versus as-needed intranasal corticosteroid use in pediatric allergic rhinitis
D3.375 - The impact of strontium exposure on allergic rhinitis development via IRE1-mediated protein expression: ECHO-COCOA study
D3.376 - The severity of the dyspnea and symptom components of COPD determines the disease course
D3.377 - Eosinophil-derived neurotoxin measured in nasal mucosal lining fluid (Nasosorption) is a promising type 2 biomarker in allergic rhinitis
D3.378 - Long Covid in epithelial barrier type2 disease: an Italian experience
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download